{"transactions":[{"id":916941,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-06T23:11:21.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":424,"price":247.15,"value":104791.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents: (i) 1,275 shares acquired via stock purchases by Reporting Owner, and (ii) 5,623 vested RSUs treated as common stock equivalents. Following termination of Reporting Person's service as a director, vested RSUs will be settled with Issuer's common stock."}],"balance_after":6898,"source":{"system":"sec-edgar","filing":"0000105132-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513226000011/form4.xml","form_type":"4"}},{"id":972114,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-13T01:09:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":612,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on June 16, 2025. This RSU award, which was granted effective December 12, 2025 and had an aggregate fair market value of approximately $125,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on June 16, 2025. This RSU award, which was granted effective December 12, 2025 and had an aggregate fair market value of approximately $125,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents: (i) 851 shares acquired via stock purchases by Reporting Owner, and (ii) 5,623 vested RSUs treated as common stock equivalents. Following termination of Reporting Person's service as a director, vested RSUs will be settled with Issuer's common stock."}],"balance_after":6474,"source":{"system":"sec-edgar","filing":"0000105132-25-000123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513225000123/form4.xml","form_type":"4"}},{"id":1011671,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-30T20:55:42.000Z","date":"2025-10-30","kind":"purchase","planned":false,"acquired":true,"shares":523,"price":196.37,"value":102701.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents: (i)  851 shares acquired via stock purchases by Reporting Owner, and (ii) 5,011 vested RSUs (previously reported as 5,018 in error) treated as common stock equivalents. Following termination of Reporting Person's service as a director, vested RSUs will be settled with Issuer's common stock."}],"balance_after":5862,"source":{"system":"sec-edgar","filing":"0000105132-25-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513225000093/form4.xml","form_type":"4"}},{"id":1331626,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-16T21:17:32.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":412,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on October 3, 2024.  This RSU award, which was granted effective December 12, 2024 and had an aggregate fair market value of approximately $110,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on October 3, 2024.  This RSU award, which was granted effective December 12, 2024 and had an aggregate fair market value of approximately $110,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents: (i) 328 shares acquired via stock purchases by Reporting Owner, and (ii) 5,018 vested RSUs treated as common stock equivalents.  Following termination of Reporting Person's service as a director, vested RSUs will be settled with Issuer's common stock."}],"balance_after":5346,"source":{"system":"sec-edgar","filing":"0000105132-24-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513224000111/form4.xml","form_type":"4"}},{"id":1542866,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-12T20:17:35.000Z","date":"2024-04-12","kind":"purchase","planned":false,"acquired":true,"shares":328,"price":234.75,"value":76998.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents: (i) 328 shares acquired via stock purchases by Reporting Owner, and (ii) 4,606 vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, vested RSUs will be settled with Issuer's common stock."}],"balance_after":4934,"source":{"system":"sec-edgar","filing":"0000105132-24-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513224000027/form4.xml","form_type":"4"}},{"id":1713257,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-13T14:26:45.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":406,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 5, 2023.  This RSU award, which was granted effective December 12, 2023 and had an aggregate fair market value of approximately $97,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 5, 2023.  This RSU award, which was granted effective December 12, 2023 and had an aggregate fair market value of approximately $97,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":4606,"source":{"system":"sec-edgar","filing":"0000105132-23-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513223000103/form4.xml","form_type":"4"}},{"id":1864429,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-06-07T16:20:34.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":219.79,"value":329685.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 56.7807 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan."}],"balance_after":89729,"source":{"system":"sec-edgar","filing":"0001127602-23-018089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223018089/form4.xml","form_type":"4"}},{"id":1904830,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-05-04T23:49:20.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":237.64,"value":356460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022."}],"balance_after":91172,"source":{"system":"sec-edgar","filing":"0001127602-23-014596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223014596/form4.xml","form_type":"4"}},{"id":1925816,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-04-05T19:28:32.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":218.23,"value":327345.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022."}],"balance_after":92672,"source":{"system":"sec-edgar","filing":"0001127602-23-012530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223012530/form4.xml","form_type":"4"}},{"id":1967065,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-03-07T17:32:03.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":1500,"price":216.69,"value":325035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022."}],"balance_after":94172,"source":{"system":"sec-edgar","filing":"0001127602-23-009228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223009228/form4.xml","form_type":"4"}},{"id":2031093,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-02-06T18:55:16.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":1500,"price":224.5,"value":336750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":95672,"source":{"system":"sec-edgar","filing":"0001127602-23-003509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223003509/form4.xml","form_type":"4"}},{"id":2063942,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2023-01-05T17:54:55.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1500,"price":210.07,"value":315105.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":97172,"source":{"system":"sec-edgar","filing":"0001127602-23-000789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223000789/form4.xml","form_type":"4"}},{"id":2085877,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T21:09:22.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":840,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an elective and a non-elective restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 12, 2021.  This RSU award, which was effective December 13, 2022, had an aggregate fair market value of approximately $140,000 on such date, and vests immediately.  The award was composed of 360 elective RSUs (representing approximately $60,000 of annual base compensation for directors) and 480 non-elective RSUs (representing approximately $80,000 of annual director compensation)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents an elective and a non-elective restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 12, 2021.  This RSU award, which was effective December 13, 2022, had an aggregate fair market value of approximately $140,000 on such date, and vests immediately.  The award was composed of 360 elective RSUs (representing approximately $60,000 of annual base compensation for directors) and 480 non-elective RSUs (representing approximately $80,000 of annual director compensation)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":4200,"source":{"system":"sec-edgar","filing":"0001567619-22-021646","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000156761922021646/doc1.xml","form_type":"4"}},{"id":2094960,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-12-06T20:07:38.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":1500,"price":229.81,"value":344715.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":98672,"source":{"system":"sec-edgar","filing":"0001127602-22-026963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026963/form4.xml","form_type":"4"}},{"id":2102808,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed  Common Stock Options","published_at":"2022-11-29T18:58:36.000Z","date":"2022-11-25","kind":"exercise","acquired":false,"shares":683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":12540,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":683},"source":{"system":"sec-edgar","filing":"0001127602-22-026463","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026463/form4.xml","form_type":"4"}},{"id":2102807,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-29T18:58:36.000Z","date":"2022-11-28","kind":"gift","acquired":false,"shares":7300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares."}],"balance_after":100172,"source":{"system":"sec-edgar","filing":"0001127602-22-026463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026463/form4.xml","form_type":"4"}},{"id":2102806,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-29T18:58:36.000Z","date":"2022-11-25","kind":"exercise","acquired":true,"shares":683,"price":146.34,"value":99950.22,"ownership":{"direct":true},"balance_after":107472,"source":{"system":"sec-edgar","filing":"0001127602-22-026463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026463/form4.xml","form_type":"4"}},{"id":2105687,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-23T22:37:27.000Z","date":"2022-11-23","kind":"tax_withholding","acquired":false,"shares":6911,"price":224.4,"value":1550828.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019."}],"balance_after":106789,"source":{"system":"sec-edgar","filing":"0001127602-22-026352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026352/form4.xml","form_type":"4"}},{"id":2105686,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-23T22:37:27.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":12389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met."}],"balance_after":113700,"source":{"system":"sec-edgar","filing":"0001127602-22-026352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026352/form4.xml","form_type":"4"}},{"id":2116859,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-15T23:26:02.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":279,"price":225.18,"value":62825.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021."}],"balance_after":101311,"source":{"system":"sec-edgar","filing":"0001127602-22-025655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222025655/form4.xml","form_type":"4"}},{"id":2116858,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-15T23:26:02.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":337,"price":225.18,"value":75885.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020."}],"balance_after":101590,"source":{"system":"sec-edgar","filing":"0001127602-22-025655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222025655/form4.xml","form_type":"4"}},{"id":2116857,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-15T23:26:02.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":450,"price":225.18,"value":101331.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019."}],"balance_after":101927,"source":{"system":"sec-edgar","filing":"0001127602-22-025655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222025655/form4.xml","form_type":"4"}},{"id":2124786,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-11-04T15:34:47.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":1545,"price":215.23,"value":332530.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":102334,"source":{"system":"sec-edgar","filing":"0001127602-22-024941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222024941/form4.xml","form_type":"4"}},{"id":2142793,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-10-05T15:35:09.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":1545,"price":220.19,"value":340193.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":103879,"source":{"system":"sec-edgar","filing":"0001127602-22-023624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222023624/form4.xml","form_type":"4"}},{"id":2164588,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-09-07T20:54:14.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":1545,"price":216.92,"value":335141.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":105424,"source":{"system":"sec-edgar","filing":"0001127602-22-022156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222022156/form4.xml","form_type":"4"}},{"id":2177328,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-08-22T19:09:44.000Z","date":"2022-08-18","kind":"grant","acquired":true,"shares":1683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant."}],"balance_after":106969,"source":{"system":"sec-edgar","filing":"0001127602-22-021424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222021424/form4.xml","form_type":"4"}},{"id":2194815,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-08-04T21:24:47.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":1545,"price":240.72,"value":371912.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":105286,"source":{"system":"sec-edgar","filing":"0001127602-22-020493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222020493/form4.xml","form_type":"4"}},{"id":2212766,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-07-06T22:31:52.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":1545,"price":212.33,"value":328049.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":106831,"source":{"system":"sec-edgar","filing":"0001127602-22-019009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222019009/form4.xml","form_type":"4"}},{"id":2240805,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-06-07T12:35:43.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":1545,"price":209.44,"value":323584.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62.7151 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan."}],"balance_after":108376,"source":{"system":"sec-edgar","filing":"0001127602-22-016949","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222016949/form4.xml","form_type":"4"}},{"id":2282877,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-05-04T21:03:17.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":1545,"price":200,"value":309000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":109858,"source":{"system":"sec-edgar","filing":"0001127602-22-013220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222013220/form4.xml","form_type":"4"}},{"id":2305797,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-04-05T20:33:53.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":1544,"price":246.6,"value":380750.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":111403,"source":{"system":"sec-edgar","filing":"0001127602-22-011560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222011560/form4.xml","form_type":"4"}},{"id":2351434,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2022-03-04T19:04:25.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":1544,"price":250.62,"value":386957.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":112947,"source":{"system":"sec-edgar","filing":"0001127602-22-008215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222008215/form4.xml","form_type":"4"}},{"id":2412092,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administration Officer"}}],"security":"ResMed Common Stock","published_at":"2022-02-05T00:14:28.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":1544,"price":232.87,"value":359551.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":114491,"source":{"system":"sec-edgar","filing":"0001127602-22-003444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222003444/form4.xml","form_type":"4"}},{"id":2451475,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administration Officer"}}],"security":"ResMed Common Stock","published_at":"2022-01-04T23:12:52.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1544,"price":258.52,"value":399154.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":116035,"source":{"system":"sec-edgar","filing":"0001127602-22-000662","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222000662/form4.xml","form_type":"4"}},{"id":2472447,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T01:07:41.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":581,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for non-elective and elective portions of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for non-elective and elective portions of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total represents 3,360 Restricted Stock Units (Common Stock equivalents)."}],"balance_after":3360,"source":{"system":"sec-edgar","filing":"0001567619-21-022125","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000156761921022125/doc1.xml","form_type":"4"}},{"id":2484274,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-12-06T21:57:26.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":1544,"price":257.93,"value":398243.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":117579,"source":{"system":"sec-edgar","filing":"0001127602-21-030371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221030371/form4.xml","form_type":"4"}},{"id":2501489,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administration Officer"}}],"security":"ResMed Common Stock Options","published_at":"2021-11-23T01:00:28.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":5931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2022, 2023 and 2024."}],"balance_after":5931,"derivative":{"exercise_price":263.16,"exercise_date":"2022-11-11","expiration_date":"2028-11-18","underlying":"ResMed Common Stock","underlying_shares":5931},"source":{"system":"sec-edgar","filing":"0000943819-21-000039","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381921000039/primary_doc.xml","form_type":"4"}},{"id":2505446,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-18T21:04:05.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant.  The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date."}],"balance_after":119123,"source":{"system":"sec-edgar","filing":"0001127602-21-029539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029539/form4.xml","form_type":"4"}},{"id":2505445,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-18T21:04:05.000Z","date":"2021-11-17","kind":"tax_withholding","acquired":false,"shares":9655,"price":254.81,"value":2460190.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018."}],"balance_after":118137,"source":{"system":"sec-edgar","filing":"0001127602-21-029539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029539/form4.xml","form_type":"4"}},{"id":2505444,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-18T21:04:05.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":17307,"price":254.81,"value":4409996.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met."}],"balance_after":127792,"source":{"system":"sec-edgar","filing":"0001127602-21-029539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029539/form4.xml","form_type":"4"}},{"id":2513674,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2021-11-15T19:06:03.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":18468,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":983},"source":{"system":"sec-edgar","filing":"0001127602-21-029097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029097/form4.xml","form_type":"4"}},{"id":2513673,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-15T19:06:03.000Z","date":"2021-11-11","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization.  Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 64.3996 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan."}],"balance_after":110485,"source":{"system":"sec-edgar","filing":"0001127602-21-029097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029097/form4.xml","form_type":"4"}},{"id":2513672,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-15T19:06:03.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":983,"price":101.64,"value":99912.12,"ownership":{"direct":true},"balance_after":120485,"source":{"system":"sec-edgar","filing":"0001127602-21-029097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029097/form4.xml","form_type":"4"}},{"id":2513671,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-15T19:06:03.000Z","date":"2021-11-11","kind":"tax_withholding","acquired":false,"shares":1549,"price":259.47,"value":401919.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018, 11/21/2019 and 11/19/2020."}],"balance_after":119502,"source":{"system":"sec-edgar","filing":"0001127602-21-029097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029097/form4.xml","form_type":"4"}},{"id":2523649,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-11-05T15:57:12.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":1485,"price":264.29,"value":392470.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":120987,"source":{"system":"sec-edgar","filing":"0001127602-21-028432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221028432/form4.xml","form_type":"4"}},{"id":2550086,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-10-05T16:57:18.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":1487,"price":260.79,"value":387794.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":122472,"source":{"system":"sec-edgar","filing":"0001127602-21-026630","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221026630/form4.xml","form_type":"4"}},{"id":2577838,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-09-07T16:57:43.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":1487,"price":292.16,"value":434441.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":123959,"source":{"system":"sec-edgar","filing":"0001127602-21-024939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221024939/form4.xml","form_type":"4"}},{"id":2595400,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-08-20T16:00:46.000Z","date":"2021-08-19","kind":"grant","acquired":true,"shares":2033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant."}],"balance_after":125446,"source":{"system":"sec-edgar","filing":"0001127602-21-024091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221024091/form4.xml","form_type":"4"}},{"id":2615929,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-08-04T17:26:39.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":1487,"price":269.38,"value":400568.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":123413,"source":{"system":"sec-edgar","filing":"0001127602-21-023038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221023038/form4.xml","form_type":"4"}},{"id":2640037,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-07-07T19:46:35.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":1487,"price":247.12,"value":367467.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":124900,"source":{"system":"sec-edgar","filing":"0001127602-21-021673","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221021673/form4.xml","form_type":"4"}},{"id":2679912,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-06-07T17:10:16.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":1487,"price":207,"value":307809.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66.72 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan."}],"balance_after":126387,"source":{"system":"sec-edgar","filing":"0001127602-21-019336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221019336/form4.xml","form_type":"4"}},{"id":2731253,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-05-04T20:23:47.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":1487,"price":190.5,"value":283273.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":127807,"source":{"system":"sec-edgar","filing":"0001127602-21-015196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221015196/form4.xml","form_type":"4"}},{"id":2756154,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-04-06T15:12:56.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":1487,"price":196.15,"value":291675.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":129294,"source":{"system":"sec-edgar","filing":"0001127602-21-013306","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221013306/form4.xml","form_type":"4"}},{"id":2809818,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-03-04T19:09:55.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":1487,"price":191.8,"value":285206.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":130781,"source":{"system":"sec-edgar","filing":"0001127602-21-009363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221009363/form4.xml","form_type":"4"}},{"id":2877835,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-02-05T18:11:09.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":1487,"price":204.42,"value":303972.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":132268,"source":{"system":"sec-edgar","filing":"0001127602-21-004154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221004154/form4.xml","form_type":"4"}},{"id":2905028,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-01-20T00:59:54.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":1548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on January 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant.  The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date."}],"balance_after":133755,"source":{"system":"sec-edgar","filing":"0001127602-21-002066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221002066/form4.xml","form_type":"4"}},{"id":2922870,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2021-01-05T21:50:24.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":1487,"price":213.24,"value":317087.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":132207,"source":{"system":"sec-edgar","filing":"0001127602-21-000635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221000635/form4.xml","form_type":"4"}},{"id":2950907,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T00:51:39.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":475,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for non-elective and elective portions of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for non-elective and elective portions of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total represents 2,779 Restricted Stock Units (Common Stock equivalents)."}],"balance_after":2779,"source":{"system":"sec-edgar","filing":"0001567619-20-020919","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000156761920020919/doc1.xml","form_type":"4"}},{"id":2955622,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-12-07T17:41:36.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":1487,"price":208.36,"value":309831.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":133694,"source":{"system":"sec-edgar","filing":"0001127602-20-030668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220030668/form4.xml","form_type":"4"}},{"id":2963413,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-12-01T21:24:18.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":7849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Corrects original reported option grant for updated Black-Scholes valuation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Corrects original reported option grant for updated Black-Scholes valuation."}],"balance_after":7849,"derivative":{"exercise_price":211.76,"exercise_date":"2021-11-11","expiration_date":"2027-11-19","underlying":"ResMed Common Stock","underlying_shares":7849},"source":{"system":"sec-edgar","filing":"0001127602-20-030207","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220030207/form4a.xml","form_type":"4/A","original_submission_date":"2020-11-20"}},{"id":2968785,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-11-24T18:31:19.000Z","date":"2020-11-20","kind":"exercise","acquired":false,"shares":1176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":24519,"derivative":{"exercise_price":84.98,"exercise_date":"2018-11-11","expiration_date":"2024-11-16","underlying":"ResMed Common Stock","underlying_shares":1176},"source":{"system":"sec-edgar","filing":"0001127602-20-029909","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029909/form4.xml","form_type":"4"}},{"id":2968784,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-24T18:31:19.000Z","date":"2020-11-23","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization.  Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares."}],"balance_after":135181,"source":{"system":"sec-edgar","filing":"0001127602-20-029909","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029909/form4.xml","form_type":"4"}},{"id":2968783,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-24T18:31:19.000Z","date":"2020-11-20","kind":"exercise","acquired":true,"shares":1176,"price":84.98,"value":99936.48,"ownership":{"direct":true},"balance_after":145181,"source":{"system":"sec-edgar","filing":"0001127602-20-029909","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029909/form4.xml","form_type":"4"}},{"id":2971787,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-11-21T01:19:38.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":7702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents date options first become exercisable.  Options vest 1/3 annually each November 11, 2021, 2022 and 2023."}],"balance_after":7702,"derivative":{"exercise_price":211.76,"exercise_date":"2021-11-11","expiration_date":"2027-11-19","underlying":"ResMed Common Stock","underlying_shares":7702},"source":{"system":"sec-edgar","filing":"0001127602-20-029776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029776/form4.xml","form_type":"4"}},{"id":2973679,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-19T20:47:33.000Z","date":"2020-11-17","kind":"tax_withholding","acquired":false,"shares":12445,"price":214.74,"value":2672439.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017."}],"balance_after":144005,"source":{"system":"sec-edgar","filing":"0001127602-20-029557","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029557/form4.xml","form_type":"4"}},{"id":2973678,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-19T20:47:33.000Z","date":"2020-11-17","kind":"grant","acquired":true,"shares":22310,"price":214.74,"value":4790849.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on November 17, 2020, when the compensation committee certified that the performance metrics were met."}],"balance_after":156450,"source":{"system":"sec-edgar","filing":"0001127602-20-029557","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029557/form4.xml","form_type":"4"}},{"id":2981944,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-14T00:02:41.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":490,"price":212.11,"value":103933.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019."}],"balance_after":134140,"source":{"system":"sec-edgar","filing":"0001127602-20-029032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029032/form4.xml","form_type":"4"}},{"id":2981943,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-14T00:02:41.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":722,"price":212.11,"value":153143.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018."}],"balance_after":134630,"source":{"system":"sec-edgar","filing":"0001127602-20-029032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029032/form4.xml","form_type":"4"}},{"id":2981942,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-14T00:02:41.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":855,"price":212.11,"value":181354.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 78.84 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan."}],"balance_after":135352,"source":{"system":"sec-edgar","filing":"0001127602-20-029032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029032/form4.xml","form_type":"4"}},{"id":2991660,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-11-05T19:01:40.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":5918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":0,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5918},"source":{"system":"sec-edgar","filing":"0001127602-20-028220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220028220/form4.xml","form_type":"4"}},{"id":2991659,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-05T19:01:40.000Z","date":"2020-11-03","kind":"sale","acquired":false,"shares":5918,"price":201.1429,"value":1190363.6822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $197.28 to 203.32. The price reported above reflects the weighted average sale price."}],"balance_after":136128,"source":{"system":"sec-edgar","filing":"0001127602-20-028220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220028220/form4.xml","form_type":"4"}},{"id":2991658,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-11-05T19:01:40.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":5918,"price":57.76,"value":341823.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":142046,"source":{"system":"sec-edgar","filing":"0001127602-20-028220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220028220/form4.xml","form_type":"4"}},{"id":3011989,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-10-06T22:08:04.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":5919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":5918,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5919},"source":{"system":"sec-edgar","filing":"0001127602-20-026627","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220026627/form4.xml","form_type":"4"}},{"id":3011988,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-10-06T22:08:04.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":5919,"price":170.066,"value":1006620.654,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $168.72 to 171.06. The price reported above reflects the weighted average sale price."}],"balance_after":136128,"source":{"system":"sec-edgar","filing":"0001127602-20-026627","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220026627/form4.xml","form_type":"4"}},{"id":3011987,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-10-06T22:08:04.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":5919,"price":57.76,"value":341881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":142047,"source":{"system":"sec-edgar","filing":"0001127602-20-026627","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220026627/form4.xml","form_type":"4"}},{"id":3038089,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-09-04T21:00:43.000Z","date":"2020-09-03","kind":"exercise","acquired":false,"shares":5919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":11837,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5919},"source":{"system":"sec-edgar","filing":"0001127602-20-024769","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220024769/form4.xml","form_type":"4"}},{"id":3038088,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-09-04T21:00:43.000Z","date":"2020-09-03","kind":"sale","acquired":false,"shares":5919,"price":177.5155,"value":1050714.2445,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $175.44 to 181.64. The price reported above reflects the weighted average sale price."}],"balance_after":136128,"source":{"system":"sec-edgar","filing":"0001127602-20-024769","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220024769/form4.xml","form_type":"4"}},{"id":3038087,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-09-04T21:00:43.000Z","date":"2020-09-03","kind":"exercise","acquired":true,"shares":5919,"price":57.76,"value":341881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":142047,"source":{"system":"sec-edgar","filing":"0001127602-20-024769","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220024769/form4.xml","form_type":"4"}},{"id":3056411,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-08-17T15:35:50.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":2966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on August 13, 2020, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant."}],"balance_after":136128,"source":{"system":"sec-edgar","filing":"0001127602-20-023639","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220023639/form4.xml","form_type":"4"}},{"id":3070322,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-08-05T00:01:40.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":5919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":17756,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5919},"source":{"system":"sec-edgar","filing":"0001127602-20-022759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220022759/form4.xml","form_type":"4"}},{"id":3070321,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-08-05T00:01:40.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":5919,"price":201.9924,"value":1195593.0156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $200.61 to $202.98. The price reported above reflects the weighted average sale price."}],"balance_after":133162,"source":{"system":"sec-edgar","filing":"0001127602-20-022759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220022759/form4.xml","form_type":"4"}},{"id":3070320,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-08-05T00:01:40.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":5919,"price":57.76,"value":341881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted by duplicate reporting of 780 performance units earned on June 4, 2020 originally reported as banked shares on April 19, 2018."}],"balance_after":139081,"source":{"system":"sec-edgar","filing":"0001127602-20-022759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220022759/form4.xml","form_type":"4"}},{"id":3087783,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-07-07T19:14:11.000Z","date":"2020-07-06","kind":"exercise","acquired":false,"shares":5919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":23675,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5919},"source":{"system":"sec-edgar","filing":"0001127602-20-021267","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220021267/form4.xml","form_type":"4"}},{"id":3087782,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-07-07T19:14:11.000Z","date":"2020-07-06","kind":"sale","acquired":false,"shares":5919,"price":194.6427,"value":1152090.1413,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $192.70 to 197.30. The price reported above reflects the weighted average sale price."}],"balance_after":133942,"source":{"system":"sec-edgar","filing":"0001127602-20-021267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220021267/form4.xml","form_type":"4"}},{"id":3087781,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-07-07T19:14:11.000Z","date":"2020-07-06","kind":"exercise","acquired":true,"shares":5919,"price":57.76,"value":341881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":139861,"source":{"system":"sec-edgar","filing":"0001127602-20-021267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220021267/form4.xml","form_type":"4"}},{"id":3119254,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-06-08T20:39:18.000Z","date":"2020-06-04","kind":"tax_withholding","acquired":false,"shares":3483,"price":160.82,"value":560136.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 6/1/2017."}],"balance_after":133942,"source":{"system":"sec-edgar","filing":"0001127602-20-019135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220019135/form4.xml","form_type":"4"}},{"id":3119253,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-06-08T20:39:18.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":7022,"price":160.82,"value":1129278.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on June 1, 2017. The shares were earned on June 4, 2020, when the compensation committee certified that the performance metrics were met."}],"balance_after":137425,"source":{"system":"sec-edgar","filing":"0001127602-20-019135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220019135/form4.xml","form_type":"4"}},{"id":3121081,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-06-05T16:32:22.000Z","date":"2020-06-03","kind":"exercise","acquired":false,"shares":5919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":29594,"derivative":{"exercise_price":57.76,"exercise_date":"2017-11-11","expiration_date":"2023-11-16","underlying":"ResMed Common Stock","underlying_shares":5919},"source":{"system":"sec-edgar","filing":"0001127602-20-018985","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220018985/form4.xml","form_type":"4"}},{"id":3121080,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-06-05T16:32:22.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":5919,"price":160.6116,"value":950660.0604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $159.05 to 162.18. The price reported above reflects the weighted average sale price."}],"balance_after":130403,"source":{"system":"sec-edgar","filing":"0001127602-20-018985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220018985/form4.xml","form_type":"4"}},{"id":3121079,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-06-05T16:32:22.000Z","date":"2020-06-03","kind":"exercise","acquired":true,"shares":5919,"price":57.76,"value":341881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":136322,"source":{"system":"sec-edgar","filing":"0001127602-20-018985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220018985/form4.xml","form_type":"4"}},{"id":3127867,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-06-03T01:37:16.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":239,"price":161.12,"value":38507.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 6/1/2017."}],"balance_after":130403,"source":{"system":"sec-edgar","filing":"0001127602-20-018554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220018554/form4.xml","form_type":"4"}},{"id":3160037,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-05-06T20:31:07.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":4737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":0,"derivative":{"exercise_price":58.24,"exercise_date":"2016-11-11","expiration_date":"2022-11-19","underlying":"ResMed Common Stock","underlying_shares":4737},"source":{"system":"sec-edgar","filing":"0001127602-20-015628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220015628/form4.xml","form_type":"4"}},{"id":3160036,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-05-06T20:31:07.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":4737,"price":155.0592,"value":734515.4304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $153.33 to 158.02. The price reported above reflects the weighted average sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 78.522 shares of ResMed stock purchased on April 30, 2020, through the ResMed Employee Stock Purchase Plan."}],"balance_after":130642,"source":{"system":"sec-edgar","filing":"0001127602-20-015628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220015628/form4.xml","form_type":"4"}},{"id":3160035,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-05-06T20:31:07.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":4737,"price":58.24,"value":275882.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":135379,"source":{"system":"sec-edgar","filing":"0001127602-20-015628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220015628/form4.xml","form_type":"4"}},{"id":3181899,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-04-07T00:38:27.000Z","date":"2020-04-03","kind":"exercise","acquired":false,"shares":4739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":4737,"derivative":{"exercise_price":58.24,"exercise_date":"2016-11-11","expiration_date":"2022-11-19","underlying":"ResMed Common Stock","underlying_shares":4739},"source":{"system":"sec-edgar","filing":"0001127602-20-013346","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220013346/form4.xml","form_type":"4"}},{"id":3181898,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-04-07T00:38:27.000Z","date":"2020-04-03","kind":"sale","acquired":false,"shares":4739,"price":152.6277,"value":723302.6703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $148.99 to 154.59. The price reported above reflects the weighted average sale price."}],"balance_after":130564,"source":{"system":"sec-edgar","filing":"0001127602-20-013346","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220013346/form4.xml","form_type":"4"}},{"id":3181897,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-04-07T00:38:27.000Z","date":"2020-04-03","kind":"exercise","acquired":true,"shares":4739,"price":58.24,"value":275999.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":135303,"source":{"system":"sec-edgar","filing":"0001127602-20-013346","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220013346/form4.xml","form_type":"4"}},{"id":3225382,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock Options","published_at":"2020-03-05T19:33:38.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":4739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":9476,"derivative":{"exercise_price":58.24,"exercise_date":"2016-11-11","expiration_date":"2022-11-19","underlying":"ResMed Common Stock","underlying_shares":4739},"source":{"system":"sec-edgar","filing":"0001127602-20-009574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220009574/form4.xml","form_type":"4"}},{"id":3225381,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-03-05T19:33:38.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":4739,"price":166.6506,"value":789757.1934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $163.15 to 171.16. The price reported above reflects the weighted average sale price."}],"balance_after":130564,"source":{"system":"sec-edgar","filing":"0001127602-20-009574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220009574/form4.xml","form_type":"4"}},{"id":3225380,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":67497,"kind":"person","name":"PENDARVIS DAVID","position":1,"cik":"0001196723","reported_name":"PENDARVIS DAVID","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"ResMed Common Stock","published_at":"2020-03-05T19:33:38.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":4739,"price":58.24,"value":275999.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."}],"balance_after":135303,"source":{"system":"sec-edgar","filing":"0001127602-20-009574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220009574/form4.xml","form_type":"4"}}],"next_cursor":"2020-03-05T19:33:38.000000Z,3225380"}